Physician profile
Michael Kogan
NPI 1699110502
$10,078.46
in general payments reported to CMS, 2019-2025
14 companies · $799 in 2025
The $799 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $5,109 · 2021: $1,071 · 2022: $807 · 2023: $628 · 2024: $1,664 · 2025: $799.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,493 · Travel and Lodging: $598.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,492.91 |
| Travel and Lodging | $598.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $5,612.03 | 2020-2025 | General - Dbs |
| Neuropace, INC. | $1,512.27 | 2022-2025 | |
| Medtronic, INC. | $794.40 | 2021-2024 | Percept Pc Brainsense, Intellis Adaptivestim, Visualase |
| Stryker Corporation | $651.09 | 2021-2025 | Na, N/A, Sonopet Iq |
| Abbott Laboratories | $415.72 | 2021 | |
| Livanova USA, INC. | $384.67 | 2022-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Dixi Medical USA Corp | $258.03 | 2021-2022 | |
| Medtronic USA, INC. | $108.69 | 2020 | |
| Brainlab, INC. | $92.23 | 2022 | |
| Monteris Medical Corporation | $67.65 | 2022 | |
| Vb Spine LLC | $52.99 | 2025 | Yukon Oct Spinal System |
| Omniscient Neurotechnology America Ltd | $48.41 | 2023 | Quicktome |
| Jazz Pharmaceuticals INC. | $45.83 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $34.45 | 2023 | Exparel, Zilretta, Iovera |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Kogan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.